Clinical Trials

160 enrolled

Solid Tumor, Adult

NCT06462794 2026-05-15

First In Human Study of CX-801 in Advanced Solid Tumors

121 enrolled

Solid Tumor, Adult

NCT05582850 2026-05-12

EPRAD

29 enrolled 12 charts

Solid Tumor, Adult

NCT07159828 2026-05-06

A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors

3 enrolled

Solid Tumor, Adult

NCT06144671 2026-04-27

GT201 Injection For The Treatment Of Advanced Solid Tumors

18 enrolled

Solid Tumor, Adult

NCT04219254 2026-04-15

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

197 enrolled

Solid Tumor, Adult

NCT05763004 2026-03-27

A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors

140 enrolled

Solid Tumor, Adult

NCT06554795 2026-03-27

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

360 enrolled

Solid Tumor, Adult

NCT04221204 2026-03-25

A Monotherapy in Subjects With Advanced Solid Tumors

42 enrolled

Solid Tumor, Adult

NCT00571389 2026-03-18

A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.

Recruiting

1,500 enrolled

Solid Tumor, Adult

NCT05689853 2026-03-18

Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors

87 enrolled

Solid Tumor, Adult

NCT06391918 2026-03-13

Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

37 enrolled

Phase NA Active not recruiting

Solid Tumor, Adult

NCT07137195 2026-02-27

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei)

47 enrolled

Solid Tumor, Adult

NCT05381909 2026-02-20

A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors

157 enrolled

Solid Tumor, Adult

NCT06507306 2026-02-06

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

100 enrolled

Solid Tumor, Adult

NCT06397963 2026-01-26

Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours

Phase NA Recruiting

18 enrolled

Solid Tumor, Adult

NCT04504942 2026-01-23

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

Phase 2 Completed

16 enrolled 16 charts

Phase NA Active not recruiting

Solid Tumor, Adult

NCT07153094 2026-01-16

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Shenzhen)

47 enrolled

Phase 1 Not yet recruiting

Solid Tumor, Adult

NCT07294872 2026-01-16

A Study of TIL in Advanced Solid Tumors (CZ)

30 enrolled

Phase 1/2 Active not recruiting

Solid Tumor, Adult

NCT04725474 2026-01-12

GDFATHER

263 enrolled

Solid Tumor, Adult

NCT06265727 2026-01-08

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

348 enrolled

Solid Tumor, Adult

NCT03905148 2026-01-07

Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors

91 enrolled

Phase NA Active not recruiting

Solid Tumor, Adult

NCT07152353 2026-01-07

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Sichuan)

47 enrolled

Solid Tumor, Adult

NCT05307874 2025-12-24

EVICTION-2

56 enrolled

Solid Tumor, Adult

NCT06088004 2025-08-22

Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors

218 enrolled

Solid Tumor, Adult

NCT03990233 2025-06-26

A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours

100 enrolled

Solid Tumor, Adult

NCT05435339 2025-04-22

A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy

Phase 1/2 Terminated

31 enrolled 29 charts

Solid Tumor, Adult

NCT06462716 2025-04-13

A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors

36 enrolled

Phase 1/2 Active not recruiting

Solid Tumor, Adult

NCT04585035 2025-03-18

Study to Evaluate D-1553 in Subjects With Solid Tumors

180 enrolled

Other solid neoplasmThoracic

Solid Tumor, Adult

NCT04597541 2025-03-10

A Study of AK112 for Advanced Solid Tumors

59 enrolled

Solid Tumor, Adult

NCT04105335 2025-03-06

TIMEPOINT

50 enrolled

Solid Tumor, Adult

NCT05559541 2025-02-19

Study of AK119 Combined With AK104 in Patients With Advanced Solid Tumors

Phase 1/2 Terminated

33 enrolled

Solid Tumor, Adult

NCT05601219 2025-01-28

A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors

46 enrolled

Solid Tumor, Adult

NCT06524804 2024-12-18

A Phase Ib/II Study of BY101298 , an Oral DNA-PK Inhibitor, Combined with Radiotherapy in Patients with Malignant Solid Tumors

Phase 1/2 Terminated

60 enrolled

Solid Tumor, Adult

NCT04020185 2024-12-11

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

40 enrolled 16 charts

Solid Tumor, Adult

NCT06026254 2024-11-18

A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial

2 enrolled

Solid Tumor, Adult

NCT06622486 2024-11-07

First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors

50 enrolled

Solid Tumor, Adult

NCT03516123 2024-09-19

A Study of CS3006 in Subjects with Locally Advanced or Metastatic Solid Tumors

18 enrolled

Solid Tumor, Adult

NCT03523819 2024-09-19

A Study of CS1002 in Subjects with Advanced Solid Tumors

91 enrolled

Solid Tumor, Adult

NCT05117177 2024-09-19

New Formulation Study of Inupadenant (EOS100850) in Patients with Cancer

57 enrolled

Solid Tumor, Adult

NCT03355066 2024-08-09

A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors

82 enrolled

Solid Tumor, Adult

NCT04121442 2024-08-06

Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors

15 enrolled

Phase 1 Not yet recruiting

Solid Tumor, Adult

NCT06473948 2024-06-25

To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects

27 enrolled

Solid Tumor, Adult

NCT05054348 2024-06-04

First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients With Advanced Solid Tumors

91 enrolled

Solid Tumor, Adult

NCT05309187 2024-06-04

Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors

22 enrolled

Solid Tumor, Adult

NCT06433726 2024-05-30

A Phase l Study of By101921, an Oral PARP7 Inhibitor, in Patients With Advanced Solid Tumors

Phase 1 Unknown

60 enrolled

Solid Tumor, Adult

NCT04092673 2024-05-21

Zotatifin

Phase 1/2 Unknown

30 enrolled

Solid Tumor, Adult

NCT05868174 2024-05-01

Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors

GenitourinaryOther solid neoplasm

36 enrolled

Solid Tumor, Adult

NCT06348290 2024-04-04

Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects

Phase 1 Unknown

72 enrolled